Capecitabine is widely utilized in research focused on:
Cancer Treatment: Primarily used as an oral chemotherapy agent for treating breast and colorectal cancers, offering a convenient alternative to intravenous therapies.
Combination Therapy: Frequently combined with other chemotherapeutic agents to enhance efficacy and reduce resistance, making it a versatile option in oncology.
Personalized Medicine: Research is ongoing into genetic markers that predict patient response, allowing for tailored treatment plans that improve outcomes.
Pharmaceutical Development: Used in the formulation of new drug delivery systems, enhancing bioavailability and patient compliance due to its oral administration.
Clinical Trials: A key compound in numerous clinical studies aimed at optimizing cancer treatment protocols, contributing to advancements in oncology.
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine|CS-0040949|206060-40-4](http://www.jk-sci.com/cdn/shop/files/519506_200x200_crop_center.png?v=1776440652)
![[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%|9426196](http://www.jk-sci.com/cdn/shop/files/GeneralChemical_optimized_1aa2a2a5-03e8-4e56-a313-1ee0558de41d_200x200_crop_center.png?v=1776306515)
